C
RMD icon

Covestor’s ResMed RMD Stock Holding History

Covestor’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65K Sell
292
-75
-20% -$18.7K 0.05% 534
2025
Q4 		$88K Sell
367
-136
-27% -$34.8K 0.05% 643
2025
Q3 		$137K Sell
503
-2
-0.4% -$546 0.08% 386
2025
Q2 		$131K Buy
505
+46
+10% +$11K 0.08% 395
2025
Q1 		$103K Buy
459
+59
+15% +$13.8K 0.07% 474
2024
Q4 		$92K Sell
400
-51
-11% -$12.3K 0.06% 581
2024
Q3 		$111K Sell
451
-37
-8% -$8.27K 0.07% 468
2024
Q2 		$93K Sell
488
-65
-12% -$13.2K 0.06% 537
2024
Q1 		$110K Sell
553
-96
-15% -$17.6K 0.07% 479
2023
Q4 		$112K Buy
649
+240
+59% +$36.9K 0.08% 424
2023
Q3 		$61K Sell
409
-33
-7% -$5.97K 0.05% 679
2023
Q2 		$97K Buy
442
+76
+21% +$16.9K 0.07% 463
2023
Q1 		$80K Buy
366
+27
+8% +$5.86K 0.07% 509
2022
Q4 		$71K Buy
339
+49
+17% +$10.8K 0.06% 583
2022
Q3 		$63K Buy
290
+210
+263% +$47.8K 0.06% 603
2022
Q2 		$17K Sell
80
-3
-4% -$639 0.01% 1021
2022
Q1 		$20K Sell
83
-76
-48% -$18.4K 0.01% 1064
2021
Q4 		$41K Buy
+159
New +$41.3K 0.06% 656

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Covestor's RMD Position: Q1 2026 in Review

Covestor reduced its ResMed (RMD) stake by 20% in Q1 2026, selling an estimated $18.7K and leaving 292 shares worth $65K. The position accounts for 0.05% of the portfolio, ranked #534.

Covestor first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $137K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Covestor held 292 shares of ResMed worth $65K as of Q1 2026.
  • Covestor sold 75 ResMed shares in Q1 2026, an estimated $18.7K.
  • ResMed made up 0.05% of Covestor's portfolio in Q1 2026, its #534 holding.
  • Covestor first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • Covestor's ResMed position peaked at $137K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.